Research programme: antibacterials - 4SC
Alternative Names: QSB agents - 4SC; Quorum sensing blocking agents - 4SCLatest Information Update: 31 Aug 2010
At a glance
- Originator 4SC
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cystic fibrosis-associated respiratory tract infections; Staphylococcal infections
Most Recent Events
- 28 May 2005 This programme is still in active development - (BioSquare-2005)
- 24 Feb 2003 4SC's antibacterials research programme is available for licensing (http://www.4sc.de)
- 24 Feb 2003 Preclinical trials in Cystic fibrosis-associated respiratory tract infections in Europe (unspecified route)